The company sources raw materials from Supplier A and Supplier B, which accounted for 60.24% and 36.51% of total purchases respectively for the fiscal year ended September 30, 2025. Processing of maca series products is outsourced to a third party. For the Homology of Medicine and Food Series, the company acquires subsidiaries for independent production and selects high-quality finished product providers. The company leases office spaces in Florida, Hong Kong, and Beijing for its operations and currently sells products through offline channels, with plans to expand online.
Cimg Inc's Comment on Supply Chain
The company sources raw materials from Supplier A and Supplier B, which accounted for 60.24% and 36.51% of total purchases respectively for the fiscal year ended September 30, 2025. Processing of maca series products is outsourced to a third party. For the Homology of Medicine and Food Series, the company acquires subsidiaries for independent production and selects high-quality finished product providers. The company leases office spaces in Florida, Hong Kong, and Beijing for its operations and currently sells products through offline channels, with plans to expand online.
Sources:
Cimg Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cimg Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
